PubMed:32147628 / 261-526 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T8","span":{"begin":8,"end":13},"obj":"CHEBI:23888"},{"id":"T9","span":{"begin":8,"end":13},"obj":"CHEBI:23888"},{"id":"T10","span":{"begin":22,"end":33},"obj":"CHEBI:3638"},{"id":"T11","span":{"begin":22,"end":33},"obj":"CHEBI:3638"},{"id":"T12","span":{"begin":22,"end":33},"obj":"DG_10"},{"id":"T13","span":{"begin":35,"end":42},"obj":"CHEBI:57472"},{"id":"T14","span":{"begin":35,"end":42},"obj":"CHEBI:57472"},{"id":"T15","span":{"begin":35,"end":42},"obj":"DG_49"},{"id":"T16","span":{"begin":44,"end":54},"obj":"DG_28"},{"id":"T17","span":{"begin":60,"end":71},"obj":"CHEBI:119915"},{"id":"T18","span":{"begin":60,"end":71},"obj":"CHEBI:119915"},{"id":"T19","span":{"begin":60,"end":71},"obj":"DG_17"},{"id":"T20","span":{"begin":60,"end":71},"obj":"NCBITaxon:31032"},{"id":"T21","span":{"begin":168,"end":179},"obj":"NCBITaxon:11118"},{"id":"T22","span":{"begin":194,"end":202},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T42","span":{"begin":0,"end":7},"obj":"JJ"},{"id":"EnjuParser_T43","span":{"begin":8,"end":13},"obj":"NNS"},{"id":"EnjuParser_T44","span":{"begin":14,"end":18},"obj":"JJ"},{"id":"EnjuParser_T45","span":{"begin":19,"end":21},"obj":"IN"},{"id":"EnjuParser_T46","span":{"begin":22,"end":33},"obj":"NN"},{"id":"EnjuParser_T47","span":{"begin":33,"end":34},"obj":"-COMMA-"},{"id":"EnjuParser_T48","span":{"begin":35,"end":42},"obj":"NN"},{"id":"EnjuParser_T49","span":{"begin":42,"end":43},"obj":"-COMMA-"},{"id":"EnjuParser_T50","span":{"begin":44,"end":54},"obj":"NN"},{"id":"EnjuParser_T51","span":{"begin":54,"end":55},"obj":"-COMMA-"},{"id":"EnjuParser_T52","span":{"begin":56,"end":59},"obj":"CC"},{"id":"EnjuParser_T53","span":{"begin":60,"end":71},"obj":"NN"},{"id":"EnjuParser_T54","span":{"begin":72,"end":75},"obj":"VBP"},{"id":"EnjuParser_T55","span":{"begin":76,"end":85},"obj":"RB"},{"id":"EnjuParser_T56","span":{"begin":86,"end":96},"obj":"VBG"},{"id":"EnjuParser_T57","span":{"begin":97,"end":105},"obj":"JJ"},{"id":"EnjuParser_T58","span":{"begin":106,"end":113},"obj":"NNS"},{"id":"EnjuParser_T59","span":{"begin":114,"end":116},"obj":"TO"},{"id":"EnjuParser_T60","span":{"begin":117,"end":121},"obj":"VB"},{"id":"EnjuParser_T61","span":{"begin":122,"end":127},"obj":"PRP-DOLLAR-"},{"id":"EnjuParser_T62","span":{"begin":128,"end":136},"obj":"NN"},{"id":"EnjuParser_T63","span":{"begin":137,"end":140},"obj":"CC"},{"id":"EnjuParser_T64","span":{"begin":141,"end":147},"obj":"NN"},{"id":"EnjuParser_T65","span":{"begin":148,"end":150},"obj":"IN"},{"id":"EnjuParser_T66","span":{"begin":151,"end":154},"obj":"DT"},{"id":"EnjuParser_T67","span":{"begin":155,"end":164},"obj":"NN"},{"id":"EnjuParser_T68","span":{"begin":165,"end":167},"obj":"IN"},{"id":"EnjuParser_T69","span":{"begin":168,"end":179},"obj":"NN"},{"id":"EnjuParser_T70","span":{"begin":180,"end":187},"obj":"NN"},{"id":"EnjuParser_T71","span":{"begin":188,"end":192},"obj":"CD"},{"id":"EnjuParser_T72","span":{"begin":193,"end":194},"obj":"-LRB-"},{"id":"EnjuParser_T73","span":{"begin":194,"end":202},"obj":"NN"},{"id":"EnjuParser_T74","span":{"begin":202,"end":203},"obj":"-RRB-"},{"id":"EnjuParser_T75","span":{"begin":204,"end":206},"obj":"IN"},{"id":"EnjuParser_T76","span":{"begin":207,"end":212},"obj":"NNP"},{"id":"EnjuParser_T77","span":{"begin":212,"end":213},"obj":"-SEMICOLON-"},{"id":"EnjuParser_T78","span":{"begin":214,"end":218},"obj":"DT"},{"id":"EnjuParser_T79","span":{"begin":219,"end":228},"obj":"JJ"},{"id":"EnjuParser_T80","span":{"begin":229,"end":236},"obj":"NNS"},{"id":"EnjuParser_T81","span":{"begin":237,"end":241},"obj":"VBP"},{"id":"EnjuParser_T82","span":{"begin":242,"end":246},"obj":"VBN"},{"id":"EnjuParser_T83","span":{"begin":247,"end":255},"obj":"VBN"},{"id":"EnjuParser_T84","span":{"begin":256,"end":260},"obj":"RB"},{"id":"EnjuParser_T85","span":{"begin":261,"end":264},"obj":"RB"}],"relations":[{"id":"EnjuParser_R43","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T42"},{"id":"EnjuParser_R44","pred":"arg1Of","subj":"EnjuParser_T45","obj":"EnjuParser_T44"},{"id":"EnjuParser_R45","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T45"},{"id":"EnjuParser_R46","pred":"arg2Of","subj":"EnjuParser_T52","obj":"EnjuParser_T45"},{"id":"EnjuParser_R47","pred":"arg1Of","subj":"EnjuParser_T46","obj":"EnjuParser_T47"},{"id":"EnjuParser_R48","pred":"arg2Of","subj":"EnjuParser_T48","obj":"EnjuParser_T47"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T49"},{"id":"EnjuParser_R50","pred":"arg2Of","subj":"EnjuParser_T50","obj":"EnjuParser_T49"},{"id":"EnjuParser_R51","pred":"arg1Of","subj":"EnjuParser_T52","obj":"EnjuParser_T51"},{"id":"EnjuParser_R52","pred":"arg1Of","subj":"EnjuParser_T49","obj":"EnjuParser_T52"},{"id":"EnjuParser_R53","pred":"arg2Of","subj":"EnjuParser_T53","obj":"EnjuParser_T52"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T54"},{"id":"EnjuParser_R55","pred":"arg2Of","subj":"EnjuParser_T56","obj":"EnjuParser_T54"},{"id":"EnjuParser_R56","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T55"},{"id":"EnjuParser_R57","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T56"},{"id":"EnjuParser_R58","pred":"arg2Of","subj":"EnjuParser_T58","obj":"EnjuParser_T56"},{"id":"EnjuParser_R59","pred":"arg1Of","subj":"EnjuParser_T58","obj":"EnjuParser_T57"},{"id":"EnjuParser_R60","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T59"},{"id":"EnjuParser_R61","pred":"modOf","subj":"EnjuParser_T56","obj":"EnjuParser_T59"},{"id":"EnjuParser_R62","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T60"},{"id":"EnjuParser_R63","pred":"arg2Of","subj":"EnjuParser_T63","obj":"EnjuParser_T60"},{"id":"EnjuParser_R64","pred":"arg1Of","subj":"EnjuParser_T63","obj":"EnjuParser_T61"},{"id":"EnjuParser_R65","pred":"arg1Of","subj":"EnjuParser_T62","obj":"EnjuParser_T63"},{"id":"EnjuParser_R66","pred":"arg2Of","subj":"EnjuParser_T64","obj":"EnjuParser_T63"},{"id":"EnjuParser_R67","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T65"},{"id":"EnjuParser_R68","pred":"arg2Of","subj":"EnjuParser_T67","obj":"EnjuParser_T65"},{"id":"EnjuParser_R69","pred":"arg1Of","subj":"EnjuParser_T67","obj":"EnjuParser_T66"},{"id":"EnjuParser_R70","pred":"arg1Of","subj":"EnjuParser_T67","obj":"EnjuParser_T68"},{"id":"EnjuParser_R71","pred":"arg2Of","subj":"EnjuParser_T70","obj":"EnjuParser_T68"},{"id":"EnjuParser_R72","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T69"},{"id":"EnjuParser_R73","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T71"},{"id":"EnjuParser_R74","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T72"},{"id":"EnjuParser_R75","pred":"arg2Of","subj":"EnjuParser_T73","obj":"EnjuParser_T72"},{"id":"EnjuParser_R76","pred":"arg3Of","subj":"EnjuParser_T74","obj":"EnjuParser_T72"},{"id":"EnjuParser_R77","pred":"arg1Of","subj":"EnjuParser_T67","obj":"EnjuParser_T75"},{"id":"EnjuParser_R78","pred":"arg2Of","subj":"EnjuParser_T76","obj":"EnjuParser_T75"},{"id":"EnjuParser_R79","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T77"},{"id":"EnjuParser_R80","pred":"arg2Of","subj":"EnjuParser_T83","obj":"EnjuParser_T77"},{"id":"EnjuParser_R81","pred":"arg1Of","subj":"EnjuParser_T80","obj":"EnjuParser_T78"},{"id":"EnjuParser_R82","pred":"arg1Of","subj":"EnjuParser_T80","obj":"EnjuParser_T79"},{"id":"EnjuParser_R83","pred":"arg1Of","subj":"EnjuParser_T80","obj":"EnjuParser_T81"},{"id":"EnjuParser_R84","pred":"arg2Of","subj":"EnjuParser_T83","obj":"EnjuParser_T81"},{"id":"EnjuParser_R85","pred":"arg1Of","subj":"EnjuParser_T80","obj":"EnjuParser_T82"},{"id":"EnjuParser_R86","pred":"arg2Of","subj":"EnjuParser_T83","obj":"EnjuParser_T82"},{"id":"EnjuParser_R87","pred":"arg2Of","subj":"EnjuParser_T80","obj":"EnjuParser_T83"},{"id":"EnjuParser_R88","pred":"arg1Of","subj":"EnjuParser_T85","obj":"EnjuParser_T84"},{"id":"EnjuParser_R89","pred":"arg1Of","subj":"EnjuParser_T83","obj":"EnjuParser_T85"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T4","span":{"begin":0,"end":265},"obj":"DRI_Background"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-OGER","denotations":[{"id":"T1","span":{"begin":22,"end":33},"obj":"CHEBI:3638"},{"id":"T2","span":{"begin":261,"end":264},"obj":"PR:000022738"},{"id":"T2","span":{"begin":72,"end":75},"obj":"SO:0001853"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T2","span":{"begin":168,"end":187},"obj":"Disease:MESH:D018352"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":265},"obj":"Sentence"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok48","span":{"begin":0,"end":7},"obj":"JJ"},{"id":"tok49","span":{"begin":8,"end":13},"obj":"NNS"},{"id":"tok50","span":{"begin":14,"end":18},"obj":"JJ"},{"id":"tok51","span":{"begin":19,"end":21},"obj":"IN"},{"id":"tok52","span":{"begin":22,"end":33},"obj":"NN"},{"id":"tok53","span":{"begin":33,"end":34},"obj":","},{"id":"tok54","span":{"begin":35,"end":42},"obj":"NN"},{"id":"tok55","span":{"begin":42,"end":43},"obj":","},{"id":"tok56","span":{"begin":44,"end":54},"obj":"NN"},{"id":"tok57","span":{"begin":54,"end":55},"obj":","},{"id":"tok58","span":{"begin":56,"end":59},"obj":"CC"},{"id":"tok59","span":{"begin":60,"end":71},"obj":"NN"},{"id":"tok60","span":{"begin":72,"end":75},"obj":"VBP"},{"id":"tok61","span":{"begin":76,"end":85},"obj":"RB"},{"id":"tok62","span":{"begin":86,"end":96},"obj":"VBG"},{"id":"tok63","span":{"begin":97,"end":105},"obj":"JJ"},{"id":"tok64","span":{"begin":106,"end":113},"obj":"NNS"},{"id":"tok65","span":{"begin":114,"end":116},"obj":"TO"},{"id":"tok66","span":{"begin":117,"end":121},"obj":"VB"},{"id":"tok67","span":{"begin":122,"end":127},"obj":"PRP$"},{"id":"tok68","span":{"begin":128,"end":136},"obj":"NN"},{"id":"tok69","span":{"begin":137,"end":140},"obj":"CC"},{"id":"tok70","span":{"begin":141,"end":147},"obj":"NN"},{"id":"tok71","span":{"begin":148,"end":150},"obj":"IN"},{"id":"tok72","span":{"begin":151,"end":154},"obj":"DT"},{"id":"tok73","span":{"begin":155,"end":164},"obj":"NN"},{"id":"tok74","span":{"begin":165,"end":167},"obj":"IN"},{"id":"tok75","span":{"begin":168,"end":179},"obj":"JJ"},{"id":"tok76","span":{"begin":180,"end":187},"obj":"NN"},{"id":"tok77","span":{"begin":188,"end":192},"obj":"CD"},{"id":"tok78","span":{"begin":193,"end":194},"obj":"("},{"id":"tok79","span":{"begin":194,"end":200},"obj":"NNP"},{"id":"tok80","span":{"begin":200,"end":202},"obj":"CD"},{"id":"tok81","span":{"begin":202,"end":203},"obj":")"},{"id":"tok82","span":{"begin":204,"end":206},"obj":"IN"},{"id":"tok83","span":{"begin":207,"end":212},"obj":"NNP"},{"id":"tok84","span":{"begin":212,"end":213},"obj":":"},{"id":"tok85","span":{"begin":214,"end":218},"obj":"DT"},{"id":"tok86","span":{"begin":219,"end":228},"obj":"JJ"},{"id":"tok87","span":{"begin":229,"end":236},"obj":"NNS"},{"id":"tok88","span":{"begin":237,"end":241},"obj":"VBP"},{"id":"tok89","span":{"begin":242,"end":246},"obj":"VBN"},{"id":"tok90","span":{"begin":247,"end":255},"obj":"VBN"},{"id":"tok91","span":{"begin":256,"end":260},"obj":"RB"},{"id":"tok92","span":{"begin":261,"end":264},"obj":"RB"},{"id":"tok93","span":{"begin":264,"end":265},"obj":"."},{"id":"lookup13","span":{"begin":19,"end":21},"obj":"country_code"},{"id":"lookup14","span":{"begin":114,"end":116},"obj":"country_code"},{"id":"lookup15","span":{"begin":148,"end":150},"obj":"country_code"},{"id":"lookup16","span":{"begin":188,"end":192},"obj":"year"},{"id":"lookup17","span":{"begin":204,"end":206},"obj":"country_code"},{"id":"lookup18","span":{"begin":207,"end":212},"obj":"location"},{"id":"event4","span":{"begin":86,"end":96},"obj":"OCCURRENCE"},{"id":"event5","span":{"begin":117,"end":121},"obj":"OCCURRENCE"},{"id":"event8","span":{"begin":247,"end":255},"obj":"OCCURRENCE"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T4","span":{"begin":168,"end":192},"obj":"Disease"},{"id":"T5","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":168,"end":192},"obj":"Disease"},{"id":"T5","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":117,"end":121},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":8,"end":13},"obj":"Chemical"},{"id":"T4","span":{"begin":22,"end":33},"obj":"Chemical"},{"id":"T5","span":{"begin":35,"end":42},"obj":"Chemical"},{"id":"T6","span":{"begin":44,"end":54},"obj":"Chemical"},{"id":"T7","span":{"begin":60,"end":71},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}

{"project":"LitCovid-PubTator","denotations":[{"id":"13","span":{"begin":22,"end":33},"obj":"Chemical"},{"id":"14","span":{"begin":35,"end":42},"obj":"Chemical"},{"id":"15","span":{"begin":44,"end":54},"obj":"Chemical"},{"id":"16","span":{"begin":60,"end":71},"obj":"Chemical"},{"id":"17","span":{"begin":168,"end":192},"obj":"Disease"},{"id":"18","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"MESH:D002738"},{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"MESH:C086979"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"MESH:C000606551"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"MESH:C462182"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:C000657245"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far."}